Kai Shuichi | Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
スポンサーリンク
概要
- Shinoda Kazutoshiの詳細を見る
- 同名の論文著者
- Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers Asの論文著者
関連著者
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Kai Shuichi
東京都健康安全研究センター
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Sagami Fumio
第一三共安全性研究所
-
Sagami Fumio
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sagami Fumio
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
Onodera Hiroshi
東京都健康安全研究センター
-
小野寺 博志
Division Of Pathology National Institute Of Health Sciences
-
Onodera Hiroshi
Pharmaceuticals And Medical Devices Agency
-
Shinoda Kazutoshi
Pharmaceuticals and Medical Devices Agency
-
Onodera H
Pharmaceuticals And Medical Devices Agency
-
Onodera Hiroshi
Dvision Of Pathology Biological Safety Research Center National Institute Of Health Sciences
-
KAI Shuichi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
SAGAMI Fumio
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Sagami Fumio
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Inoue Tohru
Biological Safety Research Center, National Institute of Health Sciences
-
Kawai Mutsufumi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Inoue Tohru
Biological Safety Research Center National Institute Of Health Sciences
-
Onodera Hiroshi
Pharmaceutical And Medical Devices Agency
-
Kai Shuichi
ブリストルマイヤーズスクイブ
-
Sagami Fumio
Japan Pharmaceutical Manufacturers Association (jpma) Qt Prodact
-
Ohno Yasuo
第一三共安全性研究所
-
Ohno Yasuo
National Institute of Health Sciences
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Kawamura Nobuyuki
European Federation of Pharmaceutical Industries and Associations
-
Yamazaki Tsuneyoshi
Kyoritsu University of Pharmacy, Kyoritsu University of Pharmacy
-
Fueki Osamu
Pharmaceuticals and Medical Devices Agency
-
Inoue Tohru
Biological Safety Res. Center National Inst. Of Health Sciences
-
Kawamura Naohisa
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
Yamazaki Tsuneyoshi
Kyoritsu University Of Pharmacy Kyoritsu University Of Pharmacy
-
Komori Masayuki
Division Of Analytical Biochemistry Faculty Of Pharmaceutical Sciences Hokkaido University
-
Ohno Yasuo
National Inst. Of Health Sci. Tokyo Jpn
-
Kudo Satoshi
Res. Center Kyorin Pharmaceutical Co. Ltd.
-
Ohno Yasuo
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
OKAHASHI Noriko
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
IKEDA Takashi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
KOMATSU Shinichi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
MATSUI Hajime
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
YAMASHITA Yasuhiro
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
YAMAMOTO Keiji
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures A
-
Matsui Hajime
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Okahashi Noriko
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Okahashi Noriko
住友化学工業
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Komatsu Shinichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Kitajima Satoshi
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Satoh Kanako
東京都健康安全研究センター 環境保健部
-
Satoh Kanako
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Nakae Dai
東京都健康安全研究センター
-
Nakae Dai
Tokyo Metropolitan Institute Of Public Health
-
Shirao Kuniaki
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Sai Kimie
Divislon Of Toxicology National Institute Of Health Sciences
-
Sai-kato Kimie
Division Of Toxicology
-
Sekita Kiyoshi
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
INOUE Tadashi
Japan Pharmaceutical Manufactures Association
-
KITAJIMA Satoshi
Division of Cellular and Molecular Toxicology, BSRC, National Institute of Health Sciences
-
Yamamoto Keiji
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Kimura Kazuya
Japan Pharmaceutical Manufacturers Assoc. Drug Evaluation Committee Non-clinical Evaluation Subcommi
-
Hisada Shigeru
Safety Research Department Developmental Research Center, ASKA Pharmaceutical Co., Ltd.
-
HISADA SHIGERU
Japan Pharmaceutical Manufacturers Association
-
WAKATA AKIHIRO
Japan Pharmaceutical Manufacturers Association
-
Yoshida Takemi
Showa Univ.
-
Hisada Shigeru
Safety Research Department Developmental Research Center Aska Pharmaceutical Co. Ltd.
-
Hisada Shigeru
Safety Research Department Aska Pharmaceutical Co. Ltd.
-
Heidel Shawn
Eli Lilly, Eli Lilly and Company
-
Kawakami Koji
Kyoto University
-
Kumagai Yuji
Showa University, School of Pharmaceutical Sciences
-
Inoue Tohru
National Institute of Health Sciences
-
Onodera Horoshi
Pharmaceuticals and Medical Devices Agency
-
Urano Tsutomu
Pharmaceuticals and Medical Devices Agency
-
Komiyama Noriyuki
Pharmaceuticals and Medical Devices Agency
-
Nishimura Chihiro
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
NAITO Shinsaku
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
FURUTA Shigeru
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
KITADA Mitsukazu
Chiba University Hospital
-
UNNO Takashi
Pharmaceutical Research and Manufactures of America
-
NAKAZAWA Takahiro
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
KAWAI Mutsufumi
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
MAKI Eiji
Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers
-
Maki E
Japan Pharmaceutical Manufacturers Assoc. Tokyo Jpn
-
Sakemi Kazue
Division Of Pharmacology And Biological Safety Research Center National Institute Of Health Sciences
-
Kawakami Koji
Dep. Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto Univ.
-
Kimura Kazuya
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Nishimura Chihiro
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Inoue Tadashi
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Kitajima S
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Fueki Osamu
Pharmaceuticals And Medical Devices Agency Shin-kasumigaseki Building
-
Kumagai Yuji
Showa University School Of Pharmaceutical Sciences
-
Heidel Shawn
Eli Lilly Eli Lilly And Company
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Furuta Shigeru
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Wakata Akihiro
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Yamashita Yasuhiro
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Kitajima S
Division Of Cellular & Molecular Toxicology Biological Safety Research Center National Institute
-
Kitajima Satoshi
Division Of Cellular And Molecular Toxicology Biological Safety Research Center National Institute O
-
Komatsu Shinichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Yoshida Takemi
Showa University School Of Pharmaceutical Sciences
-
Sagami Fumio
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Ikeda Takashi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Yamamoto Keiji
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Nakae Dai
Tokyo Metropolitan Inst. Of Public Health
-
Yamamoto Keiji
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Inoue Tohru
National Institute Of Health Science
著作論文
- The predictivity of preliminary embryo-fetal development (EFD) studies : results of a retrospective survey in Japanese pharmaceutical companies
- Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance
- Points to consider on the non-clinical safety evaluation of anticancer drugs
- CURRENT OPINION : SAFETY EVALUATION OF DRUG METABOLITES IN DEVELOPMENT OF PHARMACEUTICALS
- "POINTS TO CONSIDER" REGARDING SAFETY ASSESSMENT OF BIOTECHNOLOGY-DERIVED PHARMACEUTICALS IN NON-CLINICAL STUDIES (ENGLISH TRANSLATION)